₹150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

“The supply price of Covaxin to the government of India at ₹150 / dose, is a non-competitive price and clearly not sustainable in the long run,” Bharat Biotech said in a statement

from The Hindu - Home https://ift.tt/3iJl25R
https://ift.tt/2IyLjhI